Dr. Ed Samuel has been appointed as the Chief Operations Officer (COO) at CGT Catapult, a renowned organization focused on advancing the cell and gene therapy industry. With over two decades of experience in leading the development and delivery of advanced therapies, Dr. Samuel’s expertise spans from early research translation to regulatory approvals and global clinical manufacturing.
He has a proven track record in designing and building licensed manufacturing facilities, implementing digital and automated manufacturing platforms, and scaling operations across the UK, European Union, and USA. Dr. Samuel’s recent role as the Executive Vice President of Technical Operations at Achilles Therapeutics showcased his ability to drive operational excellence from early-stage manufacturing to commercial readiness.
Read more from thepharmaletter.com